IN8bio, Inc. Common Stock (INAB)
Since Sep 10, 2021, IN8bio, Inc. Common Stock (INAB) has reported earnings 20 times. On average the shares move ±3.19% post-earnings, with a positive reaction 55.0% of the time. Its largest post-earnings gain was +7.66% (May 12, 2023) and its largest decline was -9.51% (Nov 12, 2024). The next earnings report is predicted for 2026-11-09 (estimated).
Earnings reactions
How INAB moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±3.19%
Positive %
55.0%
Negative %
45.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | +0% | open_in_new |
| May 07, 2026 | ☽ POST | +0.95% | open_in_new |
| Mar 12, 2026 | ☽ POST | -2.51% | open_in_new |
| Nov 06, 2025 | ☽ POST | -9.36% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±3.19%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260813 | open_in_new SEC.gov |
| S-8 | 20260807 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| 424B5 | 20260601 | open_in_new SEC.gov |
| 8-K | 20260601 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260529 | open_in_new SEC.gov |
| EFFECT | 20260519 | open_in_new SEC.gov |
| S-3/A | 20260518 | open_in_new SEC.gov |
Frequently asked about INAB earnings
When does IN8bio, Inc. Common Stock report earnings next? expand_more
IN8bio, Inc. Common Stock (INAB)'s next earnings date is estimated for 2026-11-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does INAB stock move after earnings? expand_more
Over 20 reports, INAB has moved an average of ±3.19% the session after earnings, closing higher 55.0% of the time.
What was INAB's biggest post-earnings move? expand_more
INAB's largest post-earnings gain on record was +7.66% on May 12, 2023, and its largest decline was -9.51% on Nov 12, 2024.
Where can I find IN8bio, Inc. Common Stock's SEC filings? expand_more
All of IN8bio, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right